Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
80,437,115
-
Share change
-
-4,233,270
-
Total reported value
-
$1,242,500,598
-
Put/Call ratio
-
18%
-
Price per share
-
$15.47
-
Number of holders
-
310
-
Value change
-
-$66,352,882
-
Number of buys
-
142
-
Number of sells
-
120
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q3 2023
As of 30 Sep 2023,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
310 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,437,115 shares.
The largest 10 holders included
Capital Research Global Investors, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Mondrian Investment Partners LTD, MILLENNIUM MANAGEMENT LLC, MACQUARIE GROUP LTD, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and BlackRock Inc..
This page lists
310
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.